See also this year's filing and all EDGAR filings for this company.
PDF Report 0001528172_2023_ENDONOVO_THERAPEUTICS_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001528172, ENDONOVO THERAPEUTICS INC.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 15,822 |
1 | IntangibleAssetsNetIncludingGoodwill | 1,265,444 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 33,381,760 |
5 | LiabilitiesNoncurrent | 79,825 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 9,990 |
8 | SellingGeneralAndAdministrativeExpense | 0 |
9 | ResearchAndDevelopmentExpense | 0 |
10 | remainder_Expenses | 3,389,705 |
11 | remainder_Revenues | 135,355 |
12 | remainder_NetIncome | -15,210,495 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 1,281,266 |
1 | Liabilities | 33,461,585 |
2 | Expenses | 3,399,695 |
3 | Revenues | 135,355 |
4 | StockholdersEquity | -32,180,319 |
5 | NetIncome | -18,474,835 |
6 | ComprehensiveNetIncome | -18,474,835 |
7 | BaseVar | 26,744,198 |
8 | EconomicCapitalRatio | -4.25 |